Nanostructured Biomaterials

纳米结构生物材料

• 批准号: 1000219984-2010
• 负责人: Burrell, Robert
• 金额: $ 7.29万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Canada Research Chairs
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=642467
• 关键词: Nanostructured; Biomaterials

This project will develop advanced engineered delivery vehicles for the site specific delivery of nanostructured anti-inflammatory and antimicrobial compounds. These compounds are some of the most potent therapeutic agents discovered in the last 30 years. The group will also develop an understanding, at the molecular level, of how these compounds interact with the body. If the group is successful it will change the outcomes for patients with debilitating illnesses in which inflammation plays a major role. During the course of the research we will train the next generation of scientists who will engineer solutions, at the atomic level, to treat disease. This will help lead the world in the field of nanomedicine.

该项目将开发先进的工程输送工具，用于特定地点输送纳米结构抗炎和抗菌化合物。这些化合物是过去30年中发现的一些最有效的治疗剂。该小组还将在分子水平上了解这些化合物如何与人体相互作用。如果该研究成功，它将改变患有炎症起主要作用的衰弱疾病患者的结果。在研究过程中，我们将培训下一代科学家，他们将在原子水平上设计治疗疾病的解决方案。这将有助于在纳米医学领域引领世界。